TLR9-signaling is required for turning retinoic acid into a potent stimulator of RP105 (CD180)-mediated proliferation and IgG synthesis in human memory B cells

Cellular Immunology

Volumn 279, Issue 1, 2012, Pages 87-95

  Eriksen, Agnete Bratsberg ^a   Indrevær, Randi Larsen ^a   Holm, Kristine Lillebø ^a   Landskron, Johannes ^a   Blomhoff, Heidi Kiil ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

B cells; RA; Retinoic acid; RP105; TLR9

Indexed keywords

CD27 ANTIGEN; IMMUNOGLOBULIN G; PROTEIN; RETINOIC ACID; RP105 PROTEIN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD27; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; OLIGODEOXYRIBONUCLEOTIDES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; TRETINOIN;

EID: 84871663063     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.09.003     Document Type: Article

References (45)

1. Hall J.A., Grainger J.R., Spencer S.P., Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity 2011, 35:13-22.
2. Blomhoff R., Blomhoff H.K. Overview of retinoid metabolism and function. J. Neurobiol. 2006, 66:606-630.
3. Napoli J.L. Retinoic acid biosynthesis and metabolism. FASEB J. 1996, 10:993-1001.
4. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996, 10:940-954.
5. Stephensen C.B., Vitamin A. Infection, and immune function. Annu. Rev. Nutr. 2001, 21:167-192.
6. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
7. Tangye S.G., Avery D.T., Deenick E.K., Hodgkin P.D. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J. Immunol. 2003, 170:686-694.
8. Underhill D.M., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 2002, 14:103-110.
9. Kumar H., Kawai T., Akira S. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 2009, 388:621-625.
10. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
11. Ochsenbein A.F., Zinkernagel R.M. Natural antibodies and complement link innate and acquired immunity. Immunol. Today 2000, 21:624-630.
12. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003, 101:4500-4504.
13. Krieg A.M., Yi A.K., Matson S., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
14. Krieg A.M., Matson S., Fisher E. Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs. Antisense Nucleic Acid Drug Dev. 1996, 6:133-139.
15. Bode C., Zhao G., Steinhagen F., Kinjo T., Klinman D.M. CpG DNA as a vaccine adjuvant. Expert Rev. Vaccines 2011, 10:499-511.
16. Miyake K., Yamashita Y., Ogata M., Sudo T., Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 1995, 154:3333-3340.
17. Miyake K., Yamashita Y., Hitoshi Y., Takatsu K., Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 1994, 180:1217-1224.
18. Yamazaki K., Yamazaki T., Taki S., et al. Potentiation of TLR9 responses for human naive B-cell growth through RP105 signaling. Clin. Immunol. 2010, 135:125-136.
19. Blomhoff H.K., Smeland E.B., Erikstein B., et al. Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J. Biol. Chem. 1992, 267:23988-23992.
20. Ertesvag A., Aasheim H.C., Naderi S., Blomhoff H.K. Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK. Blood 2007, 109:3865-3872.
21. Ertesvag A., Naderi S., Blomhoff H.K. Regulation of B cell proliferation and differentiation by retinoic acid. Semin. Immunol. 2009, 21:36-41.
22. Naderi S., Blomhoff H.K. Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: regulation of cyclin E, cyclin A, and p21(Cip1). Blood 1999, 94:1348-1358.
23. Weston S.A., Parish C.R. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 1990, 133:87-97.
24. Blomhoff R., Green M.H., Berg T., Norum K.R. Transport and storage of vitamin A. Science 1990, 250:399-404.
25. Muindi J.R., Roth M.D., Wise R.A., et al. Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients. J. Clin. Pharmacol. 2008, 48:96-107.
26. Lomo J., Smeland E.B., Krajewski S., Reed J.C., Blomhoff H.K. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res. 1996, 56:40-43.
27. Yoshizaki K., Nakagawa T., Fukunaga K., Tseng L.T., Yamamura Y., Kishimoto T. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J. Immunol. 1984, 132:2948-2954.
28. Burdin N., Van K.C., Galibert L., et al. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 1995, 154:2533-2544.
29. Semba R.D. The role of vitamin A and related retinoids in immune function. Nutr. Rev. 1998, 56:S38-S48.
30. Booth J., Wilson H., Jimbo S., Mutwiri G. Modulation of B cell responses by Toll-like receptors. Cell Tissue Res. 2011, 343:131-140.
31. Takeshita F., Gursel I., Ishii K.J., Suzuki K., Gursel M., Klinman D.M. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin. Immunol. 2004, 16:17-22.
32. Peng S.L. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 2005, 17:230-236.
33. Good K.L., Avery D.T., Tangye S.G. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J. Immunol. 2009, 182:890-901.
34. Miura Y., Shimazu R., Miyake K., et al. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood 1998, 92:2815-2822.
35. Roshak A.K., Anderson K.M., Holmes S.D., et al. Anti-human RP105 sera induces lymphocyte proliferation. J. Leukoc. Biol. 1999, 65:43-49.
36. Chen Q., Ross A.C. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc. Natl. Acad. Sci. USA 2005, 102:14142-14149.
37. Morikawa K., Nonaka M. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. Int. Immunopharmacol. 2005, 5:1830-1838.
38. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
39. Traggiai E., Puzone R., Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 2003, 21(Suppl 2):S35-S37.
40. Tangye S.G., Hodgkin P.D. Divide and conquer: the importance of cell division in regulating B-cell responses. Immunology 2004, 112:509-520.
41. O'Connor B.P., Cascalho M., Noelle R.J. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J. Exp. Med. 2002, 195:737-745.
42. Ross A.C., Vitamin A. Supplementation and retinoic acid treatment in the regulation of antibody responses in vivo. Vitam. Horm. 2007, 75:197-222.
43. Holtick U., Scheulen M.E., von Bergwelt-Baildon M.S., Weihrauch M.R. Toll-like receptor 9 agonists as cancer therapeutics. Expert Opin. Invest. Drugs 2011, 20:361-372.
44. Ogata H., Su I., Miyake K., et al. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 2000, 192:23-29.
45. Chaplin J.W., Kasahara S., Clark E.A., Ledbetter J.A. Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway. J. Immunol. 2011, 187:4199-4209.